These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 16188676

  • 21. Clinicopathological criteria for differential diagnosis of thrombocythemias in various myeloproliferative disorders.
    Thiele J, Kvasnicka HM.
    Semin Thromb Hemost; 2006 Apr; 32(3):219-30. PubMed ID: 16673276
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Different involvement of the megakaryocytic lineage by the JAK2 V617F mutation in Polycythemia vera, essential thrombocythemia and chronic idiopathic myelofibrosis.
    Hussein K, Brakensiek K, Buesche G, Buhr T, Wiese B, Kreipe H, Bock O.
    Ann Hematol; 2007 Apr; 86(4):245-53. PubMed ID: 17262192
    [Abstract] [Full Text] [Related]

  • 24. [Novel method in diagnosis of chronic myeloproliferative disorders--detection of JAK2 mutation].
    Rajnai H, Bödör C, Reiniger L, Timár B, Csernus B, Szepesi A, Csomor J, Matolcsy A.
    Orv Hetil; 2006 Nov 12; 147(45):2175-9. PubMed ID: 17402211
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Chronic myeloproliferative disorders.
    Spivak JL, Barosi G, Tognoni G, Barbui T, Finazzi G, Marchioli R, Marchetti M.
    Hematology Am Soc Hematol Educ Program; 2003 Nov 12; ():200-24. PubMed ID: 14633783
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Myelofibrosis in chronic myeloproliferative disorders--dynamics and clinical impact.
    Thiele J, Kvasnicka HM.
    Histol Histopathol; 2006 Dec 12; 21(12):1367-78. PubMed ID: 16977587
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Megakaryopoiesis in chronic myeloproliferative diseases. A morphometric evaluation with special emphasis on primary thrombocythemia.
    Thiele J, Funke S, Holgado S, Choritz H, Georgii A.
    Anal Quant Cytol; 1984 Sep 12; 6(3):155-67. PubMed ID: 6594964
    [Abstract] [Full Text] [Related]

  • 36. [Chronic myeloproliferative diseases].
    Sréter L.
    Orv Hetil; 1998 Jul 26; 139(30):1779-83. PubMed ID: 9718944
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Modern diagnostics in chronic myeloproliferative diseases (CMPDs).
    Haferlach T, Kern W, Schnittger S, Schoch C.
    Ann Hematol; 2004 Jul 26; 83 Suppl 1():S59-61. PubMed ID: 15124674
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.